Tag: tumor | Page 3

Virus-like particle-drug conjugates induce protective, long-lasting adaptive anti-tumor immunity in the absence of specifically targeted tumor antigens

Scientific papers / 690 nm, immune checkpoints, in vitro, MLAKIT, preclinical, tumor, Uveal Melanoma / June 1, 2021

Published in: Cancer Immunology Research Authors: Rhonda C Kines, Cynthia D Thompson, Sean Spring, Zhenyu Li, Elisabet de los Pinos, Stephen Monks, John T Schiller Related application note: Vision-sparing targeted phototherapy for uveal melanoma

Virus-like particle-drug conjugates induce protective, long-lasting adaptive anti-tumor immunity in the absence of specifically targeted tumor antigens Read More »

Configurable cloud based medical laser platform with real-time treatment monitoring

Scientific papers / 5-ALA, AI, BIOS, cloud-connected, illumination, laser platform, ML7710, nanoparticle, photosensitizer, tumor / March 5, 2021

Presented in: SPIE BIOS 2021 Authors: Visa Kaivosoja, Zoe Ylöniemi, Juha Lemmetti, Timo Tanila, Lasse Orsila, Petteri Uusimaa, Modulight, Inc. (Finland)

Configurable cloud based medical laser platform with real-time treatment monitoring Read More »

An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma

Scientific papers / 690 nm, choroidal melanoma, in vitro, in vivo, IRDye700, ML6600, MLAKIT, ophthalmology, PDT, tumor, Uveal Melanoma / February 1, 2018

Published in: Molecular Cancer Therapeutics Authors: Rhonda C. Kines, Isabella Varsavsky, Sanghamitra Choudhary, Debaditya Bhattacharya, Sean Spring, Roger McLaughlin, Shin J. Kang, Hans E. Grossniklaus, Demetrios Vavvas, Stephen Monks, John R. MacDougall, Elisabet de los Pinos, and John T. Schiller

An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma Read More »